This episode features Yashar Seyed Vahedein, CEO and Co-founder of Coredio, a company tackling the significant problem of heart failure management. Yashar outlines the immense global and US prevalence of heart failure, the high rates of readmission due to inadequate post-discharge monitoring, and the substantial financial burden this places on hospitals and payers. He highlights the limitations of current standard care (blood pressure cuffs and scales) in providing timely and accurate cardiac insights, contrasting them with the invasiveness and cost of solutions like catheterization and implantable devices.

Coredio’s innovative solution is a software platform that leverages existing wearable devices (like smartwatches and blood pressure cuffs) and patented AI and physics-based technology to extract key cardiac metrics comparable to those obtained through invasive procedures. This non-invasive approach aims to improve guideline-directed medication therapy adherence, reduce hospital readmissions and length of stay, and ultimately enhance patient outcomes by providing clinicians with timely data and enabling proactive intervention – all without requiring new devices for patients or hospitals. Tune in to learn more about this exciting startup so you can be informed and inspired.

5 Key Takeaways:

1. Heart Failure is a Massive and Costly Problem: Affecting millions globally and in the US, heart failure leads to frequent hospital readmissions and billions in healthcare costs due to inadequate remote monitoring.
2. Current Home Monitoring is Insufficient: Standard post-discharge care relies on basic tools like blood pressure cuffs and scales, failing to provide the crucial real-time cardiac data needed for effective medication management.
3. Coredio Offers a Non-Invasive Solution: Their software platform utilizes existing wearables and AI to extract key cardiac metrics traditionally requiring invasive procedures, offering a more accessible and continuous monitoring option.
4. Leveraging Existing Technology for Better Care: By integrating with common wearables, Coredio avoids the need for new devices, making implementation easier for both patients and healthcare systems.
5. Significant Potential for Improved Outcomes and Cost Reduction: Coredio’s technology aims to improve medication adherence, reduce hospital readmissions and length of stay, and ultimately enhance the quality of life for heart failure patients while lowering healthcare costs.